124 related articles for article (PubMed ID: 15277425)
1. Does the aspartic acid to asparagine substitution at position 76 in the pancreas duodenum homeobox gene (PDX1) cause late-onset type 2 diabetes?
Elbein SC; Karim MA
Diabetes Care; 2004 Aug; 27(8):1968-73. PubMed ID: 15277425
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations.
Weng J; Macfarlane WM; Lehto M; Gu HF; Shepherd LM; Ivarsson SA; Wibell L; Smith T; Groop LC
Diabetologia; 2001 Feb; 44(2):249-58. PubMed ID: 11270685
[TBL] [Abstract][Full Text] [Related]
3. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.
Hani EH; Stoffers DA; Chèvre JC; Durand E; Stanojevic V; Dina C; Habener JF; Froguel P
J Clin Invest; 1999 Nov; 104(9):R41-8. PubMed ID: 10545531
[TBL] [Abstract][Full Text] [Related]
4. Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes.
Edghill EL; Khamis A; Weedon MN; Walker M; Hitman GA; McCarthy MI; Owen KR; Ellard S; T Hattersley A; Frayling TM
Diabet Med; 2011 Jun; 28(6):681-4. PubMed ID: 21569088
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
Møller AM; Ek J; Durviaux SM; Urhammer SA; Clausen JO; Eiberg H; Hansen T; Rousseau GG; Lemaigre FP; Pedersen O
Diabetologia; 1999 Aug; 42(8):1011-6. PubMed ID: 10491763
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in caucasians.
Hansen L; Urioste S; Petersen HV; Jensen JN; Eiberg H; Barbetti F; Serup P; Hansen T; Pedersen O
J Clin Endocrinol Metab; 2000 Mar; 85(3):1323-6. PubMed ID: 10720084
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes.
Macfarlane WM; Frayling TM; Ellard S; Evans JC; Allen LI; Bulman MP; Ayres S; Shepherd M; Clark P; Millward A; Demaine A; Wilkin T; Docherty K; Hattersley AT
J Clin Invest; 1999 Nov; 104(9):R33-9. PubMed ID: 10545530
[TBL] [Abstract][Full Text] [Related]
8. IPF-1/MODY4 gene missense mutation in an Italian family with type 2 and gestational diabetes.
Gragnoli C; Stanojevic V; Gorini A; Von Preussenthal GM; Thomas MK; Habener JF
Metabolism; 2005 Aug; 54(8):983-8. PubMed ID: 16092045
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the IPF1 D76N polymorphism in a worldwide type 2 diabetes population.
Gragnoli C; Cronsell J
Minerva Med; 2007 Jun; 98(3):163-6. PubMed ID: 17592437
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus.
Reis AF; Ye WZ; Dubois-Laforgue D; Bellanné-Chantelot C; Timsit J; Velho G
Eur J Endocrinol; 2000 Oct; 143(4):511-3. PubMed ID: 11022198
[TBL] [Abstract][Full Text] [Related]
11. Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.
Shiau MY; Huang CN; Liao JH; Chang YH
J Endocrinol Invest; 2004 Dec; 27(11):1076-80. PubMed ID: 15754742
[TBL] [Abstract][Full Text] [Related]
12. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
Elbein SC; Wegner K; Kahn SE
Diabetes Care; 2000 Feb; 23(2):221-7. PubMed ID: 10868835
[TBL] [Abstract][Full Text] [Related]
13. Role of the D76N polymorphism of insulin promoter factor-1 in predisposing to Type 2 diabetes.
Owen KR; Evans JC; Frayling TM; Hattersley AT; McCarthy MI; Walker M; Hitman GA
Diabetologia; 2004 May; 47(5):957-8. PubMed ID: 15170499
[No Abstract] [Full Text] [Related]
14. PDX1-MODY: A rare missense mutation as a cause of monogenic diabetes.
Abreu GM; Tarantino RM; da Fonseca ACP; de Souza RB; Soares CAPD; Cabello PH; Rodacki M; Zajdenverg L; Zembrzuski VM; Campos Junior M
Eur J Med Genet; 2021 May; 64(5):104194. PubMed ID: 33746035
[TBL] [Abstract][Full Text] [Related]
15. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
[TBL] [Abstract][Full Text] [Related]
16. Insulin Promoter Factor 1 variation is associated with type 2 diabetes in African Americans.
Karim MA; Wang X; Hale TC; Elbein SC
BMC Med Genet; 2005 Oct; 6():37. PubMed ID: 16229747
[TBL] [Abstract][Full Text] [Related]
17. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.
Celi FS; Negri C; Tanner K; Raben N; De Pablo F; Rovira A; Pallardo LF; Martin-Vaquero P; Stern MP; Mitchell BD; Shuldiner AR
Diabetes Metab Res Rev; 2000; 16(5):370-7. PubMed ID: 11025561
[TBL] [Abstract][Full Text] [Related]
18. A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency.
Nicolino M; Claiborn KC; Senée V; Boland A; Stoffers DA; Julier C
Diabetes; 2010 Mar; 59(3):733-40. PubMed ID: 20009086
[TBL] [Abstract][Full Text] [Related]
19. IPF-1 gene variation and the development of type 2 diabetes.
Silver K; Shetty A
Mol Genet Metab; 2002 Mar; 75(3):287-9. PubMed ID: 11914043
[TBL] [Abstract][Full Text] [Related]
20. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.
Hansen T; Echwald SM; Hansen L; Møller AM; Almind K; Clausen JO; Urhammer SA; Inoue H; Ferrer J; Bryan J; Aguilar-Bryan L; Permutt MA; Pedersen O
Diabetes; 1998 Apr; 47(4):598-605. PubMed ID: 9568693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
